Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • HC impleads online...

    HC impleads online medicine traders in plea seeking ban on e-pharmacies

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-03T12:43:20+05:30  |  Updated On 3 Nov 2018 12:43 PM IST
    HC impleads online medicine traders in plea seeking ban on e-pharmacies
    E-pharmacy was an initiative to help the caregivers select the most appropriate health care services at the best possible price.

    Chennai: The Madras High Court has allowed firms involved in an online sale of medicines to be impleaded in a petition seeking a ban on their business. Justice R Mahadevan, who has granted an interim stay on sale of medicines online by those not having required licence, impleaded the petitioners, including New Delhi-based 1MG Technologies Private Limited, as a party to the petition filed by the Tamil Nadu Chemists and Druggists Association (TNCDA).


    He impleaded the petitioners after hearing arguments by senior counsels for them and also the TNCDA and adjourned the matter to November 9 for further hearing.

    The Judge had on Wednesday granted an interim order restraining the online sale of medicines but clarified Thursday that his order was applicable only to those firms which do not have valid licences.

    TNCDA has sought a ban on the online sale of medicines contending that purchasing drugs from unlicensed online stores can be risky as they may sell fake, expired, contaminated or unapproved drugs that are dangerous to the health of patients.

    A battery of senior lawyers appearing for the impleading petitioners submitted their clients were only intermediaries, providing a platform between the customer and the pharmacies, and not involved in the online sale of medicines and drugs of any sort.

    E-pharmacy was an initiative to help the caregivers select the most appropriate health care services at the best possible price, the counsels said.

    Read Also: Breaking: Madras HC STAY blocks online sale of medicines


    The e-pharmacists have entered into facilitation agreements with various third-party pharmacies across the country and they neither stocked medicines nor were having any shop. The orders were placed on the basis of a prescription issued by the doctors, they said.

    Hence the online firms were not obligated to procure a license under the Drugs and Cosmetics Rules 1955, they reasoned.

    Arguing on behalf of the TNCDA, senior counsel A R L Sundaresan submitted that even for exhibition and offer of the sale itself the online companies needed a licence.

    1MG TechnologiesA R L SundaresanDrugs and Cosmetics Rules 1955e-pharmacyMadras High Courtonline sale of medicinesrestraining the online sale of medicinesstay on online sale pharmacyTamil Nadu Chemists and Druggists AssociationTNCDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok